EE04677B1 - Tetrahdropridoeetrid, nende kasutamine ja ravim - Google Patents

Tetrahdropridoeetrid, nende kasutamine ja ravim

Info

Publication number
EE04677B1
EE04677B1 EEP200100172A EEP200100172A EE04677B1 EE 04677 B1 EE04677 B1 EE 04677B1 EE P200100172 A EEP200100172 A EE P200100172A EE P200100172 A EEP200100172 A EE P200100172A EE 04677 B1 EE04677 B1 EE 04677B1
Authority
EE
Estonia
Prior art keywords
ridoethers
tetrah
medicine
drop
naphthyridine
Prior art date
Application number
EEP200100172A
Other languages
English (en)
Estonian (et)
Inventor
Senn-Bilfinger J�rg
Postius Stefan
Simon Wolfgang-Alexander
Grundler Gerhard
Hanauer Guido
Huber Reinhard
Kromer Wolfgang
Sturm Ernst
Original Assignee
Byk Gulden Lomberg Chemische Fabrik Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chemische Fabrik Gmbh filed Critical Byk Gulden Lomberg Chemische Fabrik Gmbh
Publication of EE200100172A publication Critical patent/EE200100172A/xx
Publication of EE04677B1 publication Critical patent/EE04677B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
EEP200100172A 1998-09-23 1999-09-17 Tetrahdropridoeetrid, nende kasutamine ja ravim EE04677B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19843504 1998-09-23
EP98117988 1998-09-23
PCT/EP1999/006899 WO2000017200A1 (en) 1998-09-23 1999-09-17 Tetrahydropyridoethers

Publications (2)

Publication Number Publication Date
EE200100172A EE200100172A (et) 2002-06-17
EE04677B1 true EE04677B1 (et) 2006-08-15

Family

ID=26049024

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100172A EE04677B1 (et) 1998-09-23 1999-09-17 Tetrahdropridoeetrid, nende kasutamine ja ravim

Country Status (31)

Country Link
US (4) US6436953B1 (es)
EP (1) EP1115725B1 (es)
JP (1) JP4145492B2 (es)
KR (1) KR100668400B1 (es)
CN (2) CN1155598C (es)
AT (1) ATE231862T1 (es)
AU (1) AU763463B2 (es)
BG (1) BG65195B1 (es)
BR (1) BR9914044A (es)
CA (1) CA2344251A1 (es)
CZ (1) CZ292335B6 (es)
DE (1) DE69905178T2 (es)
DK (1) DK1115725T3 (es)
EA (1) EA005377B1 (es)
EE (1) EE04677B1 (es)
ES (1) ES2191464T3 (es)
GE (1) GEP20032926B (es)
HK (1) HK1038360B (es)
HR (1) HRP20010224A2 (es)
HU (1) HUP0102990A3 (es)
ID (1) ID28896A (es)
IL (2) IL142063A0 (es)
NO (1) NO317304B1 (es)
NZ (1) NZ510610A (es)
PL (1) PL193616B1 (es)
PT (1) PT1115725E (es)
RS (1) RS50145B (es)
SI (1) SI1115725T1 (es)
SK (1) SK285165B6 (es)
TR (1) TR200100805T2 (es)
WO (1) WO2000017200A1 (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID28896A (id) 1998-09-23 2001-07-12 Byk Gulden Lomberg Chem Fab Tetrahidro pirido eter
ATE240956T1 (de) 1999-04-17 2003-06-15 Altana Pharma Ag Haloalkoxy-imidazonaphthyridine
CA2721484A1 (en) * 1999-05-12 2000-11-12 President And Fellows Of Harvard College Dopamine transporter imaging agents
JP2003528879A (ja) * 2000-03-29 2003-09-30 アルタナ ファルマ アクチエンゲゼルシャフト 三環式イミダゾピリジン
EP1313740B1 (en) * 2000-03-29 2005-11-30 ALTANA Pharma AG Prodrugs of imidazopyridine derivatives
BR0114873A (pt) * 2000-10-25 2003-07-01 Altana Pharma Ag Imidazopiridinas polissubstituìdas
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
WO2002069968A1 (en) * 2001-03-08 2002-09-12 Astrazeneca Ab New use
ATE336493T1 (de) 2001-08-02 2006-09-15 Altana Pharma Ag Tricyclische epoxide
KR20040023697A (ko) * 2001-08-03 2004-03-18 알타나 파마 아게 위장관계 장애의 치료를 위한 알킬 치환 이미다조피리딘
EP1417208A1 (en) * 2001-08-03 2004-05-12 ALTANA Pharma AG Amino-substituted imidazopyridines for the treatment of gastrointestinal diseases
BR0307708A (pt) 2002-02-15 2005-01-11 Altana Pharma Ag Compostos tricìclicos de n-acila
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
CN1652822A (zh) * 2002-05-07 2005-08-10 奥坦纳医药公司 用于治疗气道病症的可逆质子泵抑制剂和气道治疗剂的新组合
RS20050377A (en) 2002-11-19 2007-11-15 Altana Pharma Ag., 8-substituted imidazopyridines
PT1572217E (pt) 2002-12-12 2008-11-28 Nycomed Gmbh Medicamento combinado de r,r-formoterol e ciclesonida
WO2004056362A2 (en) * 2002-12-20 2004-07-08 Altana Pharma Ag 8-trialkysyloxy-2-methyl-9-phenyl-7-0 xo-7,8,9,10- tetrahydroimidazo ‘1,2-h! ‘1,7! naphthyridines
PL377581A1 (pl) * 2003-02-17 2006-02-06 Altana Pharma Ag Połączenia zawierające imidazopirydyny oraz ich zastosowanie do leczenia chorób zapalnych przewodu pokarmowego
ME00524B (me) 2003-03-10 2011-10-10 Astrazeneca Ab Novi postupak za dobijanje roflumilasta
TW200503783A (en) * 2003-04-11 2005-02-01 Altana Pharma Ag Oral pharmaceutical preparation for proton pump antagonists
SA04250092B1 (ar) * 2003-05-14 2008-05-04 التانا فاروا ايه جي مركب وسيط جديد لتحضير مركبات إيميدازوبيريدين imidazopyridines فعالة علاجياً
CA2526566A1 (en) * 2003-05-27 2004-12-09 Altana Pharma Ag Pharmaceutical combinations of a proton pump inhibitor and a compound which modifies gastrointestinal motility
BRPI0414046A (pt) * 2003-08-29 2006-10-24 Dynogen Pharmaceuticals Inc método de tratamento de um distúrbio de motilidade gastrintestinal, de tratamento de "gerd", de "gerd" noturno, composição farmacêutica, kit que compreende um composto e método para aumentar a motilidade esofágica em um paciente
PL1670482T5 (pl) 2003-09-16 2022-10-03 Covis Pharma Gmbh Zastosowanie cyklezonidu w leczeniu chorób układu oddechowego
CN101361738A (zh) 2003-11-03 2009-02-11 阿斯利康(瑞典)有限公司 治疗隐匿性胃食管反流的咪唑并[1,2-a]吡啶衍生物
EP1697358A1 (en) 2003-12-19 2006-09-06 Altana Pharma AG Intermediates for the preparation of tricyclic dihydropyrano -imidazo -pyridines derivatives
AR047605A1 (es) * 2004-02-17 2006-01-25 Altana Pharma Ag Imidazopiridinas triciclicas e intermediarios en la sintesis de las mismas,sus procesos de preparacion,composiciones farmaceuticas que los contienen y usos.
ES2426920T3 (es) 2004-09-03 2013-10-25 Yuhan Corporation Derivados de pirrolo[3,2-B]piridina y procesos para su preparación
AU2005280738B2 (en) 2004-09-03 2010-11-25 Yuhan Corporation Pyrrolo(3,2-c)pyridine derivatives and processes for the preparation thereof
KR100958829B1 (ko) 2004-09-03 2010-05-25 주식회사유한양행 피롤로[2,3-ｃ]피리딘 유도체 및 그의 제조방법
JP5383183B2 (ja) * 2005-03-16 2014-01-08 タケダ ゲゼルシャフト ミット ベシュレンクテル ハフツング ロフルミラストを含有する矯味された剤形
EP2080513A1 (en) 2008-01-16 2009-07-22 Schraermeyer, Ulrich, Prof. Dr. rer. nat Tetrahydropyridoethers for treatment of AMD
CN102470126A (zh) 2009-07-09 2012-05-23 拉夸里亚创药株式会社 用于治疗与异常肠胃运动有关的疾病的酸泵拮抗剂
WO2012027240A1 (en) * 2010-08-23 2012-03-01 Schering Corporation Fused tricyclic inhibitors of mammalian target of rapamycin
WO2013187727A1 (en) * 2012-06-15 2013-12-19 Bio-Pharm Solutions Co., Ltd. Phenylalkyl sulfamate compound and muscle relaxant composition comprising the same
WO2015052256A1 (en) 2013-10-08 2015-04-16 Katairo Gmbh Tetrahydropyridoethers for the treatment of stargardt's disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468400A (en) * 1982-12-20 1984-08-28 Schering Corporation Antiulcer tricyclic imidazo [1,2-a]pyridines
AU615666B2 (en) 1987-07-16 1991-10-10 Byk Gulden Lomberg Chemische Fabrik Gmbh New diazols
SE9401197D0 (sv) * 1994-04-11 1994-04-11 Astra Ab Active compounds
EP0773945A1 (de) * 1994-07-28 1997-05-21 Byk Gulden Lomberg Chemische Fabrik GmbH Acylimidazopyridine
PT971922E (pt) * 1997-03-24 2004-09-30 Altana Pharma Ag Compostos de tetra-hidropirido
EP0971922B1 (en) * 1997-03-24 2004-04-28 ALTANA Pharma AG Tetrahydropyrido compounds
ID28896A (id) 1998-09-23 2001-07-12 Byk Gulden Lomberg Chem Fab Tetrahidro pirido eter

Also Published As

Publication number Publication date
RS50145B (sr) 2009-03-25
NO20011243L (no) 2001-03-12
CN1319101A (zh) 2001-10-24
SK3992001A3 (en) 2001-12-03
ATE231862T1 (de) 2003-02-15
EP1115725B1 (en) 2003-01-29
WO2000017200A1 (en) 2000-03-30
HRP20010224A2 (en) 2002-04-30
DK1115725T3 (da) 2003-06-23
HK1038360B (zh) 2003-05-16
IL142063A (en) 2007-10-31
PT1115725E (pt) 2003-06-30
KR100668400B1 (ko) 2007-01-17
AU6192099A (en) 2000-04-10
CZ20011082A3 (cs) 2001-09-12
NO317304B1 (no) 2004-10-04
ES2191464T3 (es) 2003-09-01
BR9914044A (pt) 2001-12-04
BG65195B1 (bg) 2007-06-29
EE200100172A (et) 2002-06-17
CZ292335B6 (cs) 2003-09-17
ID28896A (id) 2001-07-12
US20040162310A1 (en) 2004-08-19
YU21401A (sh) 2004-03-12
CN1560055A (zh) 2005-01-05
EA200100315A1 (ru) 2001-10-22
US20020169320A1 (en) 2002-11-14
US7105676B2 (en) 2006-09-12
AU763463B2 (en) 2003-07-24
NO20011243D0 (no) 2001-03-12
US6696460B2 (en) 2004-02-24
CN100506821C (zh) 2009-07-01
PL193616B1 (pl) 2007-02-28
HUP0102990A2 (hu) 2002-01-28
TR200100805T2 (tr) 2001-08-21
HK1038360A1 (en) 2002-03-15
NZ510610A (en) 2003-07-25
BG105270A (en) 2001-11-30
PL346617A1 (en) 2002-02-25
GEP20032926B (en) 2003-03-25
KR20010075223A (ko) 2001-08-09
EA005377B1 (ru) 2005-02-24
EP1115725A1 (en) 2001-07-18
IL142063A0 (en) 2002-03-10
JP4145492B2 (ja) 2008-09-03
SI1115725T1 (en) 2003-06-30
US7393860B1 (en) 2008-07-01
US6436953B1 (en) 2002-08-20
HUP0102990A3 (en) 2002-09-30
DE69905178T2 (de) 2003-07-17
SK285165B6 (sk) 2006-07-07
CN1155598C (zh) 2004-06-30
JP2002526499A (ja) 2002-08-20
CA2344251A1 (en) 2000-03-30
DE69905178D1 (de) 2003-03-06

Similar Documents

Publication Publication Date Title
EE04677B1 (et) Tetrahdropridoeetrid, nende kasutamine ja ravim
EE04676B1 (et) Imidasopridiini derivaadid, mis inhibeerivad maohappesekretsiooni, protsess nende valmistamiseks ning nende kasutamine
EE04800B1 (et) Oraalne manustamisvorm happes ebapüsiva toimeainetarbeks, toimeaineühik, selle valmistamismeetod ja kasutamine ning meetod oraalse manustamisvormi valmistamiseks
FI974440A0 (fi) Bifenyyli-2-karboksyylihappo-tetrahydro-isokinolin-6-yyli-amidijohdannaisia, niiden valmistus ja niiden käyttö mikrosomaalistatriglyseridiä siirtävän proteiinin ja/tai apolipoproteiini B:n (Apo B) erittymiseen inhibiittoreina
NO961006L (no) Fosfonomononukleinsyrer, fremgangsmåter for fremstilling derav og anvendelse av forbindelsene
DE10299001I1 (de) Erythromycinderivate, ihre Verfahren zur Herstellung und ihre Verwendung als Arzneimittel.
DK0914119T3 (da) Fremgangsmåde til fremstilling af faste orale dosisformer af valsartan
EE9900441A (et) Farmatseutiline kompositsioon N-piperidino-3-pürasoolkarboksamiidi derivaadi, tema soolade ja nende solvaatide suu kaudu manustamiseks
EE200000315A (et) Heterotsüklilised ühendid maohappesekretsiooni inhibeerimiseks, protsess nende valmistamiseks ja ravimkoostised
EE03568B1 (et) Bensimidasooli derivaadid, nende valmistamismeetod ja kasutamine
NO882472D0 (no) Fremgangsmaate for fremstilling av peptidborsyreinhibitorer for trypsinlignende proteaser.
NO911934L (no) Fremgangsmaate for fremstilling av bicykliske 1-aza-cykloalkaner.
EE9800302A (et) Arüülglütsiinamiidi derivaadid, nende valmistamismeetod ja kasutamine ning farmatseutiline preparaat
FI990134A0 (fi) Pyridatsino-(4,5-beta)-kinoliini-5-oksidijohdannaisia, niiden valmistus ja niiden käyttö glysiiniantagonisteina
EE03682B1 (et) Asendatud bensimidasooli derivaadid, protsessid nende valmistamiseks ning nende kasutamine
DE69909577D1 (de) Derivate von Erythromycin, ihr Verfahren zur Herstellung, und ihre Verwendung als Arzneimittel
ATE242242T1 (de) Derivate von imidazo(1,2-a)pyridin zur behandlung von gastrointestinalen krankheiten
AU7788500A (en) Use of substance p antagonists for influencing the circadian timing system
IS2199B (is) Svæfandi ß-karbólín afleiður, aðferð til framleiðslu þeirra og notkun þeirra sem læknislyf
NO20003454L (no) FremgangsmÕte for fremstilling av (-)cis-3-hydroksy-1-metyl-4-
TR199800403A3 (tr) a-Bromo-laktam türevlerinin hazirlanmasi için yöntem.
NO20012541D0 (no) Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner
EE200000537A (et) Pürasolo[4,3-d]pürimidiin-7-oon-3-püridüülsulfonüülühendite ja nende vaheühendite valmistamise protsess
DE69719190D1 (de) Kolostrum enthaltende pharmazeutische zusammensetzungen und deren verwendung
FI972694A0 (fi) Uusi menetelmä sameridiinin valmistamiseksi

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20100917